Panretin Related Published Studies
Well-designed clinical trials related to Panretin (Alitretinoin Topical)
Pharmacokinetic interactions between alitretinoin and ketoconazole or simvastatin or ciclosporin A. [2011.04]
Cost-effectiveness of oral alitretinoin in patients with severe chronic hand eczema--a long-term analysis from a Swiss perspective. [2010.06.25]
Successful retreatment with alitretinoin in patients with relapsed chronic hand eczema. [2010.02.01]
Alitretinoin for severe chronic hand Eczema: a NICE single technology appraisal. [2010]
Successful retreatment with alitretinoin in patients with relapsed chronic hand
eczema. [2010]
Efficacy and safety of oral alitretinoin (9-cis retinoic acid) in patients with severe chronic hand eczema refractory to topical corticosteroids: results of a randomized, double-blind, placebo-controlled, multicentre trial. [2008.04]
Well-designed clinical trials possibly related to Panretin (Alitretinoin Topical)
Consensus statement on the management of chronic hand eczema. [2009.10]
Proliferative changes in the bronchial epithelium of former smokers treated with retinoids. [2007.11.07]
9-cis-retinoic acid treatment increases serum concentrations of alpha-tocopherol in former smokers. [2005.03.15]
Other research related to Panretin (Alitretinoin Topical)
Recent advances in the management of hand dermatitis: does alitretinoin work? [2011.05]
Everyday clinical experience of alitretinoin in the treatment of severe chronic hand eczema: seven case studies. [2011.03]
An open-label study assessing the safety and efficacy of alitretinoin in patients with severe chronic hand eczema unresponsive to topical corticosteroids. [2011.03]
Pharmacokinetic interactions between alitretinoin and ketoconazole or simvastatin
or ciclosporin A. [2011]
[Alitretinoin in chronic hand eczema: summary of clinical trials]. [2010.11]
Changes in skin barrier during treatment with systemic alitretinoin: focus on skin susceptibility and stratum corneum ceramides. [2010.11]
Alitretinoin for the treatment of severe chronic hand eczema. [2010.05]
Alitretinoin: in severe chronic hand eczema. [2009.08.20]
Everolimus: in advanced renal cell carcinoma. [2009]
[Alitretinoin: a new treatment option for chronic refractory hand eczema] [2008.09]
Alitretinoin: a comprehensive review. [2008.03]
[Kaposi's sarcoma treated with topical alitretinoin] [2007.01]
Open-label pilot study of alitretinoin gel 0.1% in the treatment of photoaging. [2005.07]
Other possibly related research studies
9-cis-Retinoic acid inhibition of lung carcinogenesis in the A/J mouse model is accompanied by increased expression of RAR-beta but no change in cyclooxygenase-2. [2006.11.28]
9-Cis-retinoic acid suppresses inflammatory responses of microglia and astrocytes. [2006.02]
Regression of NMU-induced mammary tumors with the combination of melatonin and 9-cis-retinoic acid. [2005.09.08]
Effects of 9-cis-retinoic acid on the insulin-like growth factor axis in former smokers. [2005.07.01]
Therapeutic potential of thiazolidinediones in activation of peroxisome proliferator-activated receptor gamma for monocyte recruitment and endothelial regeneration. [2005.01.31]
Schools of pharmacology: retinoid update. [2006.10]
Inhibition of lung carcinogenesis by 1alpha,25-dihydroxyvitamin D3 and 9-cis retinoic acid in the A/J mouse model: evidence of retinoid mitigation of vitamin D toxicity. [2007.04.01]
Combinational treatment with retinoic acid derivatives in non-small cell lung carcinoma in vitro. [2007.09]
Age-related change in the retinoid X receptor beta gene expression in peripheral blood mononuclear cells of healthy volunteers: effect of 13-cis retinoic acid supplementation. [2007.11]
Pegylated liposomal doxorubicin in the treatment of AIDS-related Kaposi's sarcoma. [2007]
HIV-associated Kaposi sarcoma: pathogenesis and therapy. [2007.12]
Pompholyx: what's new? [2008.06]
Low retinol levels differentially modulate bile salt-induced expression of human and mouse hepatic bile salt transporters. [2009.01]
9-Cis retinoic acid reduces 1alpha,25-dihydroxycholecalciferol-induced renal calcification by altering vitamin K-dependent gamma-carboxylation of matrix gamma-carboxyglutamic acid protein in A/J male mice. [2008.12]
[Ultraviolet therapy in patients with chronic hand eczema] [2008.09]
[New and rarley used treatment options for refractory hand eczema: local UVA-1 phototherapy, retinoids, calcineurin inhibitors] [2008.09]
Agonists of PPAR-alpha, PPAR-gamma, and RXR inhibit the formation of foam cells from macrophages in mice with inflammation. [2007.11]
Comparison of the in vitro and in vivo effects of retinoids either alone or in combination with cisplatin and 5-fluorouracil on tumor development and metastasis of melanoma. [2008.12]
9-Cis-retinoic acid reduces ischemic brain injury in rodents via bone morphogenetic protein. [2009.02]
Additive inhibitory effect of experimentally induced hepatic cirrhosis by agonists of peroxisome proliferator activator receptor gamma and retinoic acid receptor. [2009.02]
Measurement of patient-relevant benefits in the treatment of chronic hand eczema--a novel approach. [2009.07]
Combined low doses of PPARgamma and RXR ligands trigger an intrinsic apoptotic pathway in human breast cancer cells. [2009.09]
Systemic therapy of atopic dermatitis in children and adults. [2011]
Use of topical tretinoin and the development of noncutaneous adverse events: Evidence from a systematic review of the literature. [2011.12]
[Retinoids: mechanisms of action]. [2010.11]
Retinoids enhance glucocorticoid-induced apoptosis of T cells by facilitating glucocorticoid receptor-mediated transcription. [2011.05]
Pompholyx: a review of clinical features, differential diagnosis, and management. [2010]
|
